Can lamotrigine cause elevated Liver Function Tests (LFTs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Yes, lamotrigine can cause elevations in liver function tests (LFTs). This antiepileptic medication, commonly used for seizure disorders and bipolar disorder, has been associated with mild to moderate increases in liver enzymes in approximately 5-10% of patients, as reported in various studies, including 1 and 2. These elevations are typically asymptomatic and transient, often resolving even with continued treatment. However, in rare cases (estimated at less than 0.1%), lamotrigine can cause severe hepatotoxicity or drug-induced liver injury, as documented in a case report published in 1.

Risk Factors and Mechanism

Patients taking lamotrigine should have baseline LFTs checked before starting treatment, with periodic monitoring recommended, especially during the first few months of therapy. Risk factors for lamotrigine-induced liver abnormalities include concomitant use of other hepatotoxic medications (particularly valproate), pre-existing liver disease, and rapid dose escalation, as suggested by studies such as 3 and 4. The mechanism behind lamotrigine's effect on the liver likely involves the formation of reactive metabolites that can trigger immune-mediated responses or direct hepatocellular damage.

Clinical Recommendations

If a patient develops symptoms of liver dysfunction (jaundice, abdominal pain, fatigue, nausea) while on lamotrigine, the medication should be promptly discontinued and medical evaluation sought, as advised in 5. It is also crucial for prescribers to be aware of quality control concerns about some available brands of lamotrigine, as highlighted in 5, to minimize the risk of adverse effects.

Monitoring and Management

  • Baseline LFTs should be checked before starting lamotrigine.
  • Periodic monitoring of LFTs is recommended, especially during the initial months of treatment.
  • Patients should be educated on the signs of liver dysfunction and the importance of reporting these symptoms promptly.
  • In cases of suspected lamotrigine-induced liver injury, the drug should be discontinued, and the patient should undergo a thorough medical evaluation.

References

Research

Potential hepatotoxicity of lamotrigine.

Pediatric neurology, 2000

Research

Risks associated with lamotrigine prescription: a review and personal observations.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.